Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
5.04
+0.86 (20.57%)
At close: Mar 9, 2026, 4:00 PM EDT
5.04
0.00 (0.00%)
After-hours: Mar 9, 2026, 5:02 PM EDT

Lisata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
442522205028
Upgrade
Market Cap Growth
106.77%12.58%11.75%-60.48%81.39%6.25%
Upgrade
Enterprise Value
25-11-32-55-50-12
Upgrade
Last Close Price
5.042.982.732.5312.6221.45
Upgrade
PS Ratio
41.5525.02----
Upgrade
PB Ratio
2.540.850.460.300.550.86
Upgrade
P/TBV Ratio
2.580.850.460.300.550.85
Upgrade
EV/Sales Ratio
23.79-----
Upgrade
Debt / Equity Ratio
-0.010.010.010.010.02
Upgrade
Net Debt / Equity Ratio
-1.11-1.06-1.05-1.04-1.02-1.05
Upgrade
Net Debt / EBITDA Ratio
0.951.401.972.533.251.78
Upgrade
Net Debt / FCF Ratio
1.101.612.513.204.233.84
Upgrade
Asset Turnover
0.040.02----
Upgrade
Quick Ratio
4.425.897.6710.9621.009.86
Upgrade
Current Ratio
4.726.168.1811.2621.2710.08
Upgrade
Return on Equity (ROE)
-72.17%-51.77%-36.49%-68.50%-44.21%-30.84%
Upgrade
Return on Assets (ROA)
-41.86%-31.23%-25.16%-20.00%-27.30%-37.89%
Upgrade
Return on Capital Employed (ROCE)
-116.80%-76.20%-53.40%-40.80%-31.40%-58.90%
Upgrade
Earnings Yield
-41.03%-79.89%-93.79%-272.69%-54.59%-29.38%
Upgrade
FCF Yield
-38.82%-77.37%-90.15%-107.90%-44.33%-31.88%
Upgrade
Buyback Yield / Dilution
-3.87%-3.17%-55.85%-40.46%-258.29%-49.54%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.